CCLDO Q1 2026 Earnings Preferred Stock EPS Misses Estimates Flat Market Response HRI Q1 2026 Earnings Significant EPS Beat Driven by Operational Improvements THFF Q1 2026 Earnings Shares Slip Despite Narrow EPS Beat GRRR Q4 2025 Earnings Significant EPS Miss but Stock Rises Over 12 C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage NeuroOne Medical Technologies NMTC Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues to Invest in Development